2-Phenoxypyridine-3-carbonyl chloride
≥97%
- Product Code: 227960
CAS:
51362-49-3
Molecular Weight: | 233.65 g./mol | Molecular Formula: | C₁₂H₈ClNO₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C |
Product Description:
Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules and agrochemicals. Its reactive acid chloride group allows for easy amide bond formation, making it valuable in constructing complex organic structures. Commonly employed in the preparation of kinase inhibitors and other therapeutic agents where the phenoxypyridine scaffold enhances binding affinity and metabolic stability. Also utilized in research settings for the design of novel heterocyclic compounds with potential antiviral or anti-inflammatory properties.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
5g | 10-20 days | $1,929.59 |
+
-
|
2-Phenoxypyridine-3-carbonyl chloride
Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules and agrochemicals. Its reactive acid chloride group allows for easy amide bond formation, making it valuable in constructing complex organic structures. Commonly employed in the preparation of kinase inhibitors and other therapeutic agents where the phenoxypyridine scaffold enhances binding affinity and metabolic stability. Also utilized in research settings for the design of novel heterocyclic compounds with potential antiviral or anti-inflammatory properties.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :